|
17 September 2021 |
("AMS", the "Company" or the "Group")
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:
Name of applicant: |
Advanced Medical Solutions Group plc |
|||
Name of scheme: |
Block Scheme for: 1. Deferred Share Bonus Scheme 2. Enterprise Management Incentive Scheme 3. Company Share Option Plan 4. Unapproved Executive Share Option Scheme 5. Long Term Incentive Plan 6. Deferred Annual Bonus Scheme |
|||
Period of return: |
From: |
6 March 2021 |
To: |
5 September 2021 |
Balance of unallotted securities under scheme(s) from previous return: |
1. 452,678 2. Nil 3. 317,513 4. 928,904 5. 696,634 6. 344,642 |
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
1. Nil 2. Nil 3. Nil 4. Nil 5. Nil 6. Nil |
|||
Less: Number of securities issued/allotted under scheme(s) during period: |
1. 140,741 2. Nil 3. 25,952 4. 46,930 5. Nil 6. 47,973
|
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
1. 311,937 2. Nil 3. 291,561 4. 881,974 5. 696,634 6. 296,669 |
|||
Number and class of securities originally listed and the date of admission: |
4,476,264 ordinary shares of 5p each on 6 September 2018
|
|||
Name of contact: |
Eddie Johnson |
Telephone number of contact: |
01606 545506 |
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group plc |
Tel: +44 (0) 1606 545508 |
Chris Meredith, Chief Executive Officer Eddie Johnson, Chief Financial Officer Michael King, Investor Relations Manager |
|
|
|
Consilium Strategic Communications |
Tel: +44 (0) 20 3709 5700 |
Mary-Jane Elliott / Matthew Neal / Matthew Cole |
|
|
|
Investec Bank PLC - Nominated Adviser & Broker |
Tel: +44 (0) 20 7597 5970 |
Daniel Adams / Gary Clarence |
|